These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 16763212)
1. SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice. Ma Y; Cui W; Yang J; Qu J; Di C; Amin HM; Lai R; Ritz J; Krause DS; Chai L Blood; 2006 Oct; 108(8):2726-35. PubMed ID: 16763212 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of the novel oncogene SALL4 and activation of the Wnt/beta-catenin pathway in myelodysplastic syndromes. Shuai X; Zhou D; Shen T; Wu Y; Zhang J; Wang X; Li Q Cancer Genet Cytogenet; 2009 Oct; 194(2):119-24. PubMed ID: 19781444 [TBL] [Abstract][Full Text] [Related]
4. Leukemic survival factor SALL4 contributes to defective DNA damage repair. Wang F; Gao C; Lu J; Tatetsu H; Williams DA; Müller LU; Cui W; Chai L Oncogene; 2016 Nov; 35(47):6087-6095. PubMed ID: 27132514 [TBL] [Abstract][Full Text] [Related]
5. A SALL4/MLL/HOXA9 pathway in murine and human myeloid leukemogenesis. Li A; Yang Y; Gao C; Lu J; Jeong HW; Liu BH; Tang P; Yao X; Neuberg D; Huang G; Tenen DG; Chai L J Clin Invest; 2013 Oct; 123(10):4195-207. PubMed ID: 24051379 [TBL] [Abstract][Full Text] [Related]
6. High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome. Han X; Medeiros LJ; Zhang YH; You MJ; Andreeff M; Konopleva M; Bueso-Ramos CE Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S30-8. PubMed ID: 27155969 [TBL] [Abstract][Full Text] [Related]
7. Increased FLYWCH1 Expression is Negatively Correlated with Wnt/β-catenin Target Gene Expression in Acute Myeloid Leukemia Cells. Almars A; Chondrou PS; Onyido EK; Almozyan S; Seedhouse C; Babaei-Jadidi R; Nateri AS Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167387 [TBL] [Abstract][Full Text] [Related]
8. Stem cell factor SALL4, a potential prognostic marker for myelodysplastic syndromes. Wang F; Guo Y; Chen Q; Yang Z; Ning N; Zhang Y; Xu Y; Xu X; Tong C; Chai L; Cui W J Hematol Oncol; 2013 Sep; 6(1):73. PubMed ID: 24283704 [TBL] [Abstract][Full Text] [Related]
9. Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemia. Wetzler M; Kurzrock R; Estrov Z; Estey E; Talpaz M Leuk Res; 1995 Jan; 19(1):23-34. PubMed ID: 7837815 [TBL] [Abstract][Full Text] [Related]
10. Evi-1 and MDS1-Evi-1 genes in pathogenesis of myelodysplastic syndromes and post-MDS acute myeloid leukemia. Xu K; Wang L; Hao Y; Shao Z; Meng Q; Li K; Chao H; Tang K; Wang L Chin Med J (Engl); 1999 Dec; 112(12):1112-8. PubMed ID: 11721451 [TBL] [Abstract][Full Text] [Related]
11. Molecular bases of myelodysplastic syndromes: lessons from animal models. Komeno Y; Kitaura J; Kitamura T J Cell Physiol; 2009 Jun; 219(3):529-34. PubMed ID: 19259975 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-3-mediated regulation of β-catenin in myeloid transformation and acute myeloid leukemia. Sadras T; Perugini M; Kok CH; Iarossi DG; Heatley SL; Brumatti G; Samuel MS; To LB; Lewis ID; Lopez AF; Ekert PG; Ramshaw HS; D'Andrea RJ J Leukoc Biol; 2014 Jul; 96(1):83-91. PubMed ID: 24598054 [TBL] [Abstract][Full Text] [Related]
13. The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator. Soderholm J; Kobayashi H; Mathieu C; Rowley JD; Nucifora G Leukemia; 1997 Mar; 11(3):352-8. PubMed ID: 9067573 [TBL] [Abstract][Full Text] [Related]
14. Secretion and Expression of Matrix Metalloproteinase-2 and 9 from Bone Marrow Mononuclear Cells in Myelodysplastic Syndrome and Acute Myeloid Leukemia. Chaudhary AK; Chaudhary S; Ghosh K; Shanmukaiah C; Nadkarni AH Asian Pac J Cancer Prev; 2016; 17(3):1519-29. PubMed ID: 27039800 [TBL] [Abstract][Full Text] [Related]
15. PRDM16 isoforms differentially regulate normal and leukemic hematopoiesis and inflammatory gene signature. Corrigan DJ; Luchsinger LL; Justino de Almeida M; Williams LJ; Strikoudis A; Snoeck HW J Clin Invest; 2018 Aug; 128(8):3250-3264. PubMed ID: 29878897 [TBL] [Abstract][Full Text] [Related]
16. The Study of SALL4 Gene and BMI-1 Gene Expression in Acute Myeloid Leukemia Patients. Swelem RS; Elneely DA; Shehata AAR Lab Med; 2020 May; 51(3):265-270. PubMed ID: 31552409 [TBL] [Abstract][Full Text] [Related]
17. The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis. Yang L; Liu L; Gao H; Pinnamaneni JP; Sanagasetti D; Singh VP; Wang K; Mathison M; Zhang Q; Chen F; Mo Q; Rosengart T; Yang J J Hematol Oncol; 2017 Oct; 10(1):159. PubMed ID: 28974232 [TBL] [Abstract][Full Text] [Related]
18. Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing. Shitashige M; Naishiro Y; Idogawa M; Honda K; Ono M; Hirohashi S; Yamada T Gastroenterology; 2007 Mar; 132(3):1039-54. PubMed ID: 17383426 [TBL] [Abstract][Full Text] [Related]
19. Alteration of c-mpl-mediated signal transduction in CD34(+) cells from patients with myelodysplastic syndromes. Kalina U; Hofmann WK; Koschmieder S; Wagner S; Kauschat D; Hoelzer D; Ottmann OG Exp Hematol; 2000 Oct; 28(10):1158-63. PubMed ID: 11027834 [TBL] [Abstract][Full Text] [Related]